1032 related articles for article (PubMed ID: 10797570)
1. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
2. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
3. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
[TBL] [Abstract][Full Text] [Related]
4. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
6. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
Uchida M; Ozono K; Pike JW
J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
[TBL] [Abstract][Full Text] [Related]
7. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
Messerlian S; Gao X; St-Arnaud R
J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
[TBL] [Abstract][Full Text] [Related]
8. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
12. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
15. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
Bula CM; Bishop JE; Ishizuka S; Norman AW
Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
[TBL] [Abstract][Full Text] [Related]
16. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF
J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements.
Russell J; Ashok S; Koszewski NJ
J Bone Miner Res; 1999 Nov; 14(11):1828-37. PubMed ID: 10571682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
